Errol R. Halperin insider trades: Vital Therapies (VTL) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Errol reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 25, 2018 | VTL | ↓ Sell | 89,417 | $0.29 | $26K | Direct | Sep 25, 2018 (0d) |
| Sep 25, 2018 | VTL | ↓ Sell | 10,000 | $0.29 | $3K | Indirect | Sep 25, 2018 (0d) |
| Oct 8, 2014 | VTL | ↑ Buy | 3,809 | $17.50 | $67K | Direct | Oct 9, 2014 (1d) |
| Oct 8, 2014 | VTL | ↑ Buy | 1,667 | $17.50 | $29K | Indirect | Oct 9, 2014 (1d) |
| Apr 23, 2014 | VTL | ↑ Buy | 8,333 | $12.00 | $100K | Indirect | Apr 23, 2014 (0d) |
| Apr 23, 2014 | VTL | ↑ Buy | 6,191 | $12.00 | $74K | By Reporting Person and his wife | Apr 23, 2014 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Errol R. Halperin's insider trades
Errol R. Halperin is a director at Vital Therapies (VTL). Since Apr 23, 2014, Errol has reported 4 open-market purchases worth $270K and 2 sales worth $29K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (6 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VTL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.